 Shilajit<GPE> is claimed as a Vajikarak<GPE> ( aphrodisiac ) and used for the treatment of male infertility by traditional healers of the Indian<GPE> subcontinent. Therefore, the present investigation was designed to assess the effectiveness of Shilajit<GPE> for treatment of male infertility resulting from exposure to perilous chemicals. Effect of daily oral administration ( p.o. ) of Shilajit<GPE> ( 50 mg, 100 mg and 200 mg/Kg BW ) was investigated for a single spermatogenic cycle ( 35 days ) in cadmium-induced ( 2 mg/Kg BW, p.o. for 35 days ) infertile adult ( 12-14 week ) swiss male mice. Shilajit<PERSON> treatment increased weights of reproductive organs, testicular daily sperm production, activities of testicular Î”